risikostratifizierung of acute coronary syndrome using fragments / teilpeptiden of provasopressins, especially copeptin or neurophysin ii

摘要

The invention relates to a method for risk stratification for acute coronary syndrome (ACS), especially acute myocardial infarction (AMI) and angina pectoris (AP), where provasopressin (proAVP) or fragments and partial peptides thereof, especially copeptin or neurophysin II, is determined by means of an in vitro diagnosis.